查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
全球銀屑病關節炎治療市場規模研究與預測:按藥物類型（NSAIDs,DMARDs,生物製劑,其他）,類型（處方藥,OTC）,給藥途徑（局部,口服,注射）,區域分析2022-2029
市場調查報告書
商品編碼
1152009

全球銀屑病關節炎治療市場規模研究與預測:按藥物類型（NSAIDs,DMARDs,生物製劑,其他）,類型（處方藥,OTC）,給藥途徑（局部,口服,注射）,區域分析2022-2029

Global Psoriatic Arthritis Treatment Market Size study & Forecast, by Drug Type (NSAIDs, DMARDs, Biologics, and Others), Type (Prescription, and OTC), and Route of Administration (Topical, Oral, and Injectable) and Regional Analysis, 2022-2029
出版日期: | 出版商: Bizwit Research & Consulting LLP | 英文 | 商品交期: 2-3個工作天內

價格

到 2021 年，全球銀屑病關節炎治療市場價值約為 96.1 億美元，預計在 2022-2029 年的預測期內將以超過 7.2% 的健康增長率增長。

銀屑病關節炎是發生在銀屑病患者身上的一種關節炎。銀屑病關節炎會導致身體關節疼痛、腫脹和僵硬。銀屑病關節炎是一種自身免疫性疾病，身體的免疫系統會攻擊健康細胞。主要受影響的是膝蓋、腳踝、腳和手。嚴重的銀屑病關節炎可導致永久性關節畸形。治療選擇包括類固醇、注射劑和口服藥物。銀屑病關節炎發病率的上升、生物製劑和生物仿製藥滲透率的提高以及主要參與者的戰略舉措是推動市場增長的主要因素。

國家銀屑病基金會估計，到 2020 年，美國將有大約 800 萬人患有銀屑病。另一方面，銀屑病影響全世界約 1.25 億人，約佔世界人口的 2-3%。大約 30% 的銀屑病患者也會患上銀屑病關節炎。此外，預計新興國家老齡化人口的增加和醫療基礎設施的發展將為預測期內的市場創造良好的增長前景。然而，與治療相關的高成本和診斷工具缺乏標準化將阻礙 2022-2029 年預測期內的市場增長。

全球銀屑病關節炎治療市場研究考慮的主要區域包括亞太地區、北美、歐洲、中美洲和南美洲以及世界其他地區。由於銀屑病關節炎患病率上升以及該地區主要市場參與者的存在，北美是一個關鍵地區。另一方面，由於老年人口增加和醫療基礎設施發展等因素，預計亞太地區在預測期內將出現顯著增長。

本報告中的主要市場進入者包括:

  • AbbVie Inc.
  • Amgen Inc.
  • Bristol-Myers Squibb Company
  • Eli Lilly and Company.
  • Johnson & Johnson.
  • Merck & Co Inc.
  • Mylan N.V
  • Novartis AG
  • Pfizer Inc.
  • UCB S.A.

近期市場動態。

  • 2021年12月，Novartis宣布新品Cosentyx（蘇金單抗）在美國獲批用於治療4歲及以上人群的活動性腸炎相關關節炎（ERA）和活動性幼年型銀屑病關節炎（JPsA）適用於 2 歲及以上人群。經 FDA 批准。
  • 2022 年 1 月，美國食品和藥物管理局 (FDA) 批准了 AbbVie 的 Skyligi (risankizumab-rzaa)。這種新配方旨在用於治療活動性銀屑病關節炎 (PsA) 患者。

全球銀屑病關節炎治療市場研究範圍

歷史數據: 2019-2020-2021

基準估計年份:2021

預測期:2022-2029

報告的收入預測、公司排名、競爭格局、增長因素、趨勢

目標細分藥物類型、類型、給藥途徑、區域

區域範圍北美；歐洲；亞太地區；拉丁美洲；世界其他地區

購買研究報導報告即可免費定制（相當於長達 8 小時的分析師時間）。添加或更改國家、地區、航段範圍*

這項研究的目的是定義近年來各個細分市場和國家的市場規模，並預測他們在未來幾年的價值。該報告旨在捕捉被調查國家工業的定性和定量方面的情況。

它還提供了有關關鍵方面的詳細信息，例如將定義市場未來增長的驅動因素和挑戰。此外，它還包含供利益相關者投資的微觀市場潛在機會，以及對主要參與者的競爭格局和產品供應的深入分析。市場的詳細細分和子細分如下所述。

按藥物類型

非甾體抗炎藥

DMARDs

生物製品

其他

按類型

處方藥

非處方藥物

按給藥途徑

外用

口服

注射

按地區

北美

美國

加拿大

歐洲

英國

德國

法國

西班牙

意大利

歐洲其他地區

亞太地區

中國

印度

日本

澳大利亞

韓國

其他亞太地區

拉丁美洲

巴西

墨西哥

世界其他地區

目錄

第一章內容提要

  • 市場快照
  • 2019-2029 年按細分市場的全球市場估計和預測
    • 銀屑病關節炎治療市場:按地區劃分，2019-2029
    • 銀屑病關節炎治療市場:按藥物類型分類，2019-2029
    • 銀屑病關節炎治療市場:按類型分類，2019-2029
    • 銀屑病關節炎治療市場:按給藥途徑，2019-2029
  • 主要趨勢
  • 調查方法
  • 調查先決條件

2全球銀屑病關節炎治療市場:定義和範圍

  • 調查目的
  • 市場定義和範圍
    • 調查範圍
    • 產業進化
  • 調查目標年份
  • 貨幣兌換率

3 銀屑病關節炎治療的全球市場動態

  • 銀屑病關節炎治療市場影響分析（2019-2029）
    • 市場驅動力
      • 銀屑病關節炎患病率增加
      • 增加生物製劑和生物仿製藥的滲透
      • 主要市場參與者的戰略舉措
    • 市場挑戰
      • 治療費用高
      • 診斷工具缺乏標準化
    • 市場機會
      • 老年人口增加
      • 新興市場醫療保健基礎設施的增長

4 全球銀屑病關節炎治療市場:行業分析

  • 波特五力模型
    • 供應商的議價能力
    • 買方議價能力
    • 新進入者的威脅
    • 替代品的威脅
    • 競爭對手之間的競爭
  • 波特五力模型的未來方法（2019-2029）
  • PEST分析
    • 政治的
    • 經濟的
    • 社會的
    • 技術的
  • 招商引資模式
  • 分析師結論/建議
  • 頂級投資機會
  • 關鍵成功策略

第 5 章風險評估:COVID-19 的影響

  • 評估 COVID-19 對行業的整體影響
  • COVID-19 之前和 COVID-19 之後的市場情景

6 按藥物類型分列的全球銀屑病關節炎治療市場

  • 市場快照
  • 全球銀屑病關節炎治療市場:按藥物類型分列的性能潛力分析
  • 按藥物類型分列的全球銀屑病關節炎治療市場及 2019-2029 年預測
  • 全球銀屑病關節炎治療市場:細分分析
    • 非甾體抗炎藥
    • DMARDs
    • 生物製品
    • 其他

7 全球銀屑病關節炎治療市場，按類型

  • 市場快照
  • 全球銀屑病關節炎治療市場:按類型劃分的性能潛力分析
  • 全球銀屑病關節炎治療市場:按類型估算和預測:2019-2029
  • 全球銀屑病關節炎治療市場:細分分析
    • 處方藥
    • 場外交易

8 全球銀屑病關節炎治療市場，按給藥途徑

  • 市場快照
  • 全球銀屑病關節炎治療市場:按給藥途徑、性能-潛力分析
  • 全球銀屑病關節炎治療市場:按給藥途徑、估計和預測:2019-2029
  • 全球銀屑病關節炎治療市場:細分分析
    • 注射
    • 口服劑
    • 局部給藥

9 全球銀屑病關節炎治療市場:區域分析

  • 銀屑病關節炎治療市場，按地區劃分的市場概況
  • 北美
    • 美國
      • 2019-2029 年按藥物類型估算和預測
      • 按類型劃分的估計和預測，2019-2029
      • 2019-2029 年各給藥途徑的估計和預測
    • 加拿大
  • 歐洲銀屑病關節炎治療市場概況
    • 英國
    • 德國
    • 法國
    • 西班牙
    • 意大利
    • 歐洲其他地區
  • 亞太地區銀屑病關節炎治療市場概況
    • 中國
    • 印度
    • 日本
    • 澳大利亞
    • 韓國
    • 亞太其他地區
  • 拉丁美洲銀屑病關節炎治療市場概況
    • 巴西
    • 墨西哥
  • 世界其他地區

第 10 章 競爭信息

  • 頂級市場戰略
  • 公司簡介
    • AbbVie Inc.
      • 主要信息
      • 概述
      • 財務（如果有數據）
      • 產品概要
      • 近期發展狀況
    • Amgen Inc.
    • Bristol-Myers Squibb Company
    • Eli Lilly And Company.
    • Johnson & Johnson.
    • Merck & Co Inc.
    • Mylan N.V
    • Novartis AG
    • Pfizer Inc.
    • UCB S.A.

第十一章調查過程

  • 調查過程
    • 數據挖掘
    • 分析
    • 市場估計
    • 驗證
    • 出版物
  • 調查屬性
  • 調查先決條件

表格和數字列表是虛擬的，最終可交付成果可能有所不同。

Global Psoriatic Arthritis Treatment Market is valued approximately USD 9.61 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 7.2% over the forecast period 2022-2029. Psoriatic Arthritis is a form of arthritis that occurs in people affected from psoriasis. Psoriatic Arthritis causes pain, swelling and stiffness in body joints. Psoriatic Arthritis is an auto immune condition in which body's immune system attacks healthy cells of the body. It mainly affects knees, ankles, feet, and hands. Severe Psoriatic Arthritis can cause permanent deformation of joints. Its treatment options include steroids, injections, and oral drugs among others. The increasing incidence of Psoriatic Arthritis and growing penetration of biological and biosimilar therapies as well as strategic initiatives from leading market players are key factors accelerating the market growth.

According to the National Psoriasis Foundation estimates - as of 2020, around 8 million individuals in US are affected by Psoriasis. Whereas, globally around 125 million people are affected by Psoriasis, witnessing for around 2-3% of the global population. In addition, approximately 30 percent individuals with psoriasis also develop psoriatic arthritis. Also, rising number of geriatric individuals and growing healthcare infrastructure in emerging markets would create lucrative growth prospectus for the market over the forecast period. However, high Cost associated with treatment and lack of standardization of diagnosis tools impede the market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Psoriatic Arthritis Treatment Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America is the leading region due to rising prevalence of Psoriatic Arthritis as well as presence of leading market players in the region. Whereas Asia Pacific is expected to grow significantly during the forecast period, owing to factors such as rising number of geriatric individuals as well as growing healthcare infrastructure in the region.

Major market players included in this report are:

AbbVie Inc.

Amgen Inc.

Bristol-Myers Squibb Company

Eli Lilly and Company.

Johnson & Johnson.

Merck & Co Inc.

Mylan N.V

Novartis AG

Pfizer Inc.

UCB S.A.

Recent Developments in the Market:

  • In December 2021, Novartis, received approval from US FDA for its new product Cosentyx(secukinumab) for the treatment of active enthesitis-related arthritis (ERA) in four years and older, and active juvenile psoriatic arthritis (JPsA) in patients two years and older.
  • In January 2022, The US Food and Drug Administration (FDA) approved AbbVie's Skyrizi (risankizumab-rzaa). This new formulation is intended for treatment of active psoriatic arthritis (PsA) patients.

Global Psoriatic Arthritis Treatment Market Report Scope:

Historical Data: 2019-2020-2021

Base Year for Estimation: 2021

Forecast period: 2022-2029

Report Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends

Segments Covered Drug Type, Type, Route of Administration, Region

Regional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World

Customization Scope Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Drug Type

NSAIDs

DMARDs

Biologics

Others

By Type

Prescription

OTC

By Route of Administration

Topical

Oral

Injectable

By Region:

North America

U.S.

Canada

Europe

UK

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

Rest of the World

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
    • 1.2.1. Psoriatic Arthritis Treatment Market, by Region, 2019-2029 (USD Billion)
    • 1.2.2. Psoriatic Arthritis Treatment Market, by Drug Type, 2019-2029 (USD Billion)
    • 1.2.3. Psoriatic Arthritis Treatment Market, by Type, 2019-2029 (USD Billion)
    • 1.2.4. Psoriatic Arthritis Treatment Market, by Route of Administration, 2019-2029 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Psoriatic Arthritis Treatment Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Psoriatic Arthritis Treatment Market Dynamics

  • 3.1. Psoriatic Arthritis Treatment Market Impact Analysis (2019-2029)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Increasing incidence of Psoriatic Arthritis.
      • 3.1.1.2. Growing penetration of biological and biosimilar therapies
      • 3.1.1.3. Strategic initiatives from leading market players.
    • 3.1.2. Market Challenges
      • 3.1.2.1. High Cost associated with treatment.
      • 3.1.2.2. Lack of standardization of diagnosis tools.
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Rising number of geriatric individuals.
      • 3.1.3.2. Growing healthcare infrastructure in emerging markets.

Chapter 4. Global Psoriatic Arthritis Treatment Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
  • 4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
  • 4.3. PEST Analysis
    • 4.3.1. Political
    • 4.3.2. Economical
    • 4.3.3. Social
    • 4.3.4. Technological
  • 4.4. Investment Adoption Model
  • 4.5. Analyst Recommendation & Conclusion
  • 4.6. Top investment opportunity
  • 4.7. Top winning strategies

Chapter 5. Risk Assessment: COVID-19 Impact

  • 5.1. Assessment of the overall impact of COVID-19 on the industry
  • 5.2. Pre COVID-19 and post COVID-19 Market scenario

Chapter 6. Global Psoriatic Arthritis Treatment Market, by Drug Type

  • 6.1. Market Snapshot
  • 6.2. Global Psoriatic Arthritis Treatment Market by Drug Type, Performance - Potential Analysis
  • 6.3. Global Psoriatic Arthritis Treatment Market Estimates & Forecasts by Drug Type 2019-2029 (USD Billion)
  • 6.4. Psoriatic Arthritis Treatment Market, Sub Segment Analysis
    • 6.4.1. NSAIDs
    • 6.4.2. DMARDs
    • 6.4.3. Biologics
    • 6.4.4. Others

Chapter 7. Global Psoriatic Arthritis Treatment Market, by Type

  • 7.1. Market Snapshot
  • 7.2. Global Psoriatic Arthritis Treatment Market by Type, Performance - Potential Analysis
  • 7.3. Global Psoriatic Arthritis Treatment Market Estimates & Forecasts by Type 2019-2029 (USD Billion)
  • 7.4. Psoriatic Arthritis Treatment Market, Sub Segment Analysis
    • 7.4.1. Prescription
    • 7.4.2. OTC

Chapter 8. Global Psoriatic Arthritis Treatment Market, by Route of Administration

  • 8.1. Market Snapshot
  • 8.2. Global Psoriatic Arthritis Treatment Market by Route of Administration, Performance - Potential Analysis
  • 8.3. Global Psoriatic Arthritis Treatment Market Estimates & Forecasts by Route of Administration 2019-2029 (USD Billion)
  • 8.4. Psoriatic Arthritis Treatment Market, Sub Segment Analysis
    • 8.4.1. Injectable
    • 8.4.2. Oral
    • 8.4.3. Topical

Chapter 9. Global Psoriatic Arthritis Treatment Market, Regional Analysis

  • 9.1. Psoriatic Arthritis Treatment Market, Regional Market Snapshot
  • 9.2. North America Psoriatic Arthritis Treatment Market
    • 9.2.1. U.S. Psoriatic Arthritis Treatment Market
      • 9.2.1.1. Drug Type breakdown estimates & forecasts, 2019-2029
      • 9.2.1.2. Type breakdown estimates & forecasts, 2019-2029
      • 9.2.1.3. Route of Administration breakdown estimates & forecasts, 2019-2029
    • 9.2.2. Canada Psoriatic Arthritis Treatment Market
  • 9.3. Europe Psoriatic Arthritis Treatment Market Snapshot
    • 9.3.1. U.K. Psoriatic Arthritis Treatment Market
    • 9.3.2. Germany Psoriatic Arthritis Treatment Market
    • 9.3.3. France Psoriatic Arthritis Treatment Market
    • 9.3.4. Spain Psoriatic Arthritis Treatment Market
    • 9.3.5. Italy Psoriatic Arthritis Treatment Market
    • 9.3.6. Rest of Europe Psoriatic Arthritis Treatment Market
  • 9.4. Asia-Pacific Psoriatic Arthritis Treatment Market Snapshot
    • 9.4.1. China Psoriatic Arthritis Treatment Market
    • 9.4.2. India Psoriatic Arthritis Treatment Market
    • 9.4.3. Japan Psoriatic Arthritis Treatment Market
    • 9.4.4. Australia Psoriatic Arthritis Treatment Market
    • 9.4.5. South Korea Psoriatic Arthritis Treatment Market
    • 9.4.6. Rest of Asia Pacific Psoriatic Arthritis Treatment Market
  • 9.5. Latin America Psoriatic Arthritis Treatment Market Snapshot
    • 9.5.1. Brazil Psoriatic Arthritis Treatment Market
    • 9.5.2. Mexico Psoriatic Arthritis Treatment Market
  • 9.6. Rest of The World Psoriatic Arthritis Treatment Market

Chapter 10. Competitive Intelligence

  • 10.1. Top Market Strategies
  • 10.2. Company Profiles
    • 10.2.1. AbbVie Inc.
      • 10.2.1.1. Key Information
      • 10.2.1.2. Overview
      • 10.2.1.3. Financial (Subject to Data Availability)
      • 10.2.1.4. Product Summary
      • 10.2.1.5. Recent Developments
    • 10.2.2. Amgen Inc.
    • 10.2.3. Bristol-Myers Squibb Company
    • 10.2.4. Eli Lilly And Company.
    • 10.2.5. Johnson & Johnson.
    • 10.2.6. Merck & Co Inc.
    • 10.2.7. Mylan N.V
    • 10.2.8. Novartis AG
    • 10.2.9. Pfizer Inc.
    • 10.2.10. UCB S.A.

Chapter 11. Research Process

  • 11.1. Research Process
    • 11.1.1. Data Mining
    • 11.1.2. Analysis
    • 11.1.3. Market Estimation
    • 11.1.4. Validation
    • 11.1.5. Publishing
  • 11.2. Research Attributes
  • 11.3. Research Assumption
  • TABLE 1. Global Psoriatic Arthritis Treatment Market, report scope
  • TABLE 2. Global Psoriatic Arthritis Treatment Market estimates & forecasts by Region 2019-2029 (USD Billion)
  • TABLE 3. Global Psoriatic Arthritis Treatment Market estimates & forecasts by Drug Type 2019-2029 (USD Billion)
  • TABLE 4. Global Psoriatic Arthritis Treatment Market estimates & forecasts by Type 2019-2029 (USD Billion)
  • TABLE 5. Global Psoriatic Arthritis Treatment Market estimates & forecasts by Route of Administration 2019-2029 (USD Billion)
  • TABLE 6. Global Psoriatic Arthritis Treatment Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 7. Global Psoriatic Arthritis Treatment Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 8. Global Psoriatic Arthritis Treatment Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 9. Global Psoriatic Arthritis Treatment Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 10. Global Psoriatic Arthritis Treatment Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 11. Global Psoriatic Arthritis Treatment Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 12. Global Psoriatic Arthritis Treatment Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 13. Global Psoriatic Arthritis Treatment Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 14. Global Psoriatic Arthritis Treatment Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 15. Global Psoriatic Arthritis Treatment Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 16. U.S. Psoriatic Arthritis Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 17. U.S. Psoriatic Arthritis Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 18. U.S. Psoriatic Arthritis Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 19. Canada Psoriatic Arthritis Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 20. Canada Psoriatic Arthritis Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 21. Canada Psoriatic Arthritis Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 22. UK Psoriatic Arthritis Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 23. UK Psoriatic Arthritis Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 24. UK Psoriatic Arthritis Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 25. Germany Psoriatic Arthritis Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 26. Germany Psoriatic Arthritis Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 27. Germany Psoriatic Arthritis Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 28. France Psoriatic Arthritis Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 29. France Psoriatic Arthritis Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 30. France Psoriatic Arthritis Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 31. Italy Psoriatic Arthritis Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 32. Italy Psoriatic Arthritis Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 33. Italy Psoriatic Arthritis Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 34. Spain Psoriatic Arthritis Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 35. Spain Psoriatic Arthritis Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 36. Spain Psoriatic Arthritis Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 37. RoE Psoriatic Arthritis Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 38. RoE Psoriatic Arthritis Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 39. RoE Psoriatic Arthritis Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 40. China Psoriatic Arthritis Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 41. China Psoriatic Arthritis Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 42. China Psoriatic Arthritis Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 43. India Psoriatic Arthritis Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 44. India Psoriatic Arthritis Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 45. India Psoriatic Arthritis Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 46. Japan Psoriatic Arthritis Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 47. Japan Psoriatic Arthritis Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 48. Japan Psoriatic Arthritis Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 49. South Korea Psoriatic Arthritis Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 50. South Korea Psoriatic Arthritis Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 51. South Korea Psoriatic Arthritis Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 52. Australia Psoriatic Arthritis Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 53. Australia Psoriatic Arthritis Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 54. Australia Psoriatic Arthritis Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 55. RoAPAC Psoriatic Arthritis Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 56. RoAPAC Psoriatic Arthritis Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 57. RoAPAC Psoriatic Arthritis Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 58. Brazil Psoriatic Arthritis Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 59. Brazil Psoriatic Arthritis Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 60. Brazil Psoriatic Arthritis Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 61. Mexico Psoriatic Arthritis Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 62. Mexico Psoriatic Arthritis Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 63. Mexico Psoriatic Arthritis Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 64. RoLA Psoriatic Arthritis Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 65. RoLA Psoriatic Arthritis Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 66. RoLA Psoriatic Arthritis Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 67. Row Psoriatic Arthritis Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 68. Row Psoriatic Arthritis Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 69. Row Psoriatic Arthritis Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 70. List of secondary sources, used in the study of global Psoriatic Arthritis Treatment Market
  • TABLE 71. List of primary sources, used in the study of global Psoriatic Arthritis Treatment Market
  • TABLE 72. Years considered for the study
  • TABLE 73. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF TABLES

  • TABLE 1. Global Psoriatic Arthritis Treatment Market, report scope
  • TABLE 2. Global Psoriatic Arthritis Treatment Market estimates & forecasts by Region 2019-2029 (USD Billion)
  • TABLE 3. Global Psoriatic Arthritis Treatment Market estimates & forecasts by Drug Type 2019-2029 (USD Billion)
  • TABLE 4. Global Psoriatic Arthritis Treatment Market estimates & forecasts by Type 2019-2029 (USD Billion)
  • TABLE 5. Global Psoriatic Arthritis Treatment Market estimates & forecasts by Route of Administration 2019-2029 (USD Billion)
  • TABLE 6. Global Psoriatic Arthritis Treatment Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 7. Global Psoriatic Arthritis Treatment Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 8. Global Psoriatic Arthritis Treatment Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 9. Global Psoriatic Arthritis Treatment Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 10. Global Psoriatic Arthritis Treatment Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 11. Global Psoriatic Arthritis Treatment Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 12. Global Psoriatic Arthritis Treatment Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 13. Global Psoriatic Arthritis Treatment Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 14. Global Psoriatic Arthritis Treatment Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 15. Global Psoriatic Arthritis Treatment Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 16. U.S. Psoriatic Arthritis Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 17. U.S. Psoriatic Arthritis Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 18. U.S. Psoriatic Arthritis Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 19. Canada Psoriatic Arthritis Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 20. Canada Psoriatic Arthritis Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 21. Canada Psoriatic Arthritis Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 22. UK Psoriatic Arthritis Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 23. UK Psoriatic Arthritis Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 24. UK Psoriatic Arthritis Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 25. Germany Psoriatic Arthritis Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 26. Germany Psoriatic Arthritis Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 27. Germany Psoriatic Arthritis Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 28. France Psoriatic Arthritis Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 29. France Psoriatic Arthritis Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 30. France Psoriatic Arthritis Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 31. Italy Psoriatic Arthritis Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 32. Italy Psoriatic Arthritis Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 33. Italy Psoriatic Arthritis Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 34. Spain Psoriatic Arthritis Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 35. Spain Psoriatic Arthritis Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 36. Spain Psoriatic Arthritis Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 37. RoE Psoriatic Arthritis Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 38. RoE Psoriatic Arthritis Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 39. RoE Psoriatic Arthritis Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 40. China Psoriatic Arthritis Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 41. China Psoriatic Arthritis Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 42. China Psoriatic Arthritis Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 43. India Psoriatic Arthritis Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 44. India Psoriatic Arthritis Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 45. India Psoriatic Arthritis Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 46. Japan Psoriatic Arthritis Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 47. Japan Psoriatic Arthritis Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 48. Japan Psoriatic Arthritis Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 49. South Korea Psoriatic Arthritis Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 50. South Korea Psoriatic Arthritis Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 51. South Korea Psoriatic Arthritis Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 52. Australia Psoriatic Arthritis Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 53. Australia Psoriatic Arthritis Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 54. Australia Psoriatic Arthritis Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 55. RoAPAC Psoriatic Arthritis Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 56. RoAPAC Psoriatic Arthritis Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 57. RoAPAC Psoriatic Arthritis Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 58. Brazil Psoriatic Arthritis Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 59. Brazil Psoriatic Arthritis Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 60. Brazil Psoriatic Arthritis Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 61. Mexico Psoriatic Arthritis Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 62. Mexico Psoriatic Arthritis Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 63. Mexico Psoriatic Arthritis Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 64. RoLA Psoriatic Arthritis Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 65. RoLA Psoriatic Arthritis Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 66. RoLA Psoriatic Arthritis Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 67. Row Psoriatic Arthritis Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 68. Row Psoriatic Arthritis Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 69. Row Psoriatic Arthritis Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 70. List of secondary sources, used in the study of global Psoriatic Arthritis Treatment Market
  • TABLE 71. List of primary sources, used in the study of global Psoriatic Arthritis Treatment Market
  • TABLE 72. Years considered for the study
  • TABLE 73. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

List of figures

  • FIG 1. Global Psoriatic Arthritis Treatment Market, research methodology
  • FIG 2. Global Psoriatic Arthritis Treatment Market, Market estimation techniques
  • FIG 3. Global Market size estimates & forecast methods
  • FIG 4. Global Psoriatic Arthritis Treatment Market, key trends 2021
  • FIG 5. Global Psoriatic Arthritis Treatment Market, growth prospects 2022-2029
  • FIG 6. Global Psoriatic Arthritis Treatment Market, porters 5 force model
  • FIG 7. Global Psoriatic Arthritis Treatment Market, pest analysis
  • FIG 8. Global Psoriatic Arthritis Treatment Market, value chain analysis
  • FIG 9. Global Psoriatic Arthritis Treatment Market by segment, 2019 & 2029 (USD Billion)
  • FIG 10. Global Psoriatic Arthritis Treatment Market by segment, 2019 & 2029 (USD Billion)
  • FIG 11. Global Psoriatic Arthritis Treatment Market by segment, 2019 & 2029 (USD Billion)
  • FIG 12. Global Psoriatic Arthritis Treatment Market by segment, 2019 & 2029 (USD Billion)
  • FIG 13. Global Psoriatic Arthritis Treatment Market by segment, 2019 & 2029 (USD Billion)
  • FIG 14. Global Psoriatic Arthritis Treatment Market, regional snapshot 2019 & 2029
  • FIG 15. North America Psoriatic Arthritis Treatment Market 2019 & 2029 (USD Billion)
  • FIG 16. Europe Psoriatic Arthritis Treatment Market 2019 & 2029 (USD Billion)
  • FIG 17. Asia pacific Psoriatic Arthritis Treatment Market 2019 & 2029 (USD Billion)
  • FIG 18. Latin America Psoriatic Arthritis Treatment Market 2019 & 2029 (USD Billion)
  • FIG 19. Global Psoriatic Arthritis Treatment Market, company Market share analysis (2021)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable